TRACER PHARMA ApS — Credit Rating and Financial Key Figures

TRACER PHARMA ApS (CVR number: 34090106) is a company from RUDERSDAL. The company recorded a gross profit of 5412.9 kDKK in 2023. The operating profit was 2182.6 kDKK, while net earnings were 1705.3 kDKK. The profitability of the company measured by Return on Assets (ROA) was 57.4 %, which can be considered excellent and Return on Equity (ROE) was 98.8 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 58.7 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. TRACER PHARMA ApS's liquidity measured by quick ratio was 5.9 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.